• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Clinical significance of molecular detection of carcinoma cells

Research Project

Project/Area Number 10470260
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

MORI Masaki  Medical Institute of Bioregulation, Kyushu University, Professor, 生体防御医学研究所, 教授 (70190999)

Co-Investigator(Kenkyū-buntansha) SHIBUTA Kenji  Medical Institute of Bioregulation, Kyushu University, Research Associate, 生体防御医学研究所, 助手 (70253531)
INOUE Hiroshi  Medical Institute of Bioregulation, Kyushu University, Assistant Professor, 生体防御医学研究所, 講師 (90203249)
田中 真二  九州大学, 生体防御医学研究所, 助手 (30253420)
原口 勝  九州大学, 生体防御医学研究所, 講師 (40228531)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥12,800,000 (Direct Cost: ¥12,800,000)
Fiscal Year 1999: ¥5,500,000 (Direct Cost: ¥5,500,000)
Fiscal Year 1998: ¥7,300,000 (Direct Cost: ¥7,300,000)
Keywordsmicrometastasis / predictive factor / RT-PCR / MACS(magnetic cell sorting system) / CEAmRNA / K-ras mutation / sentinel lymph node / CEAmRNA / 癌微小転移 / RTーPCR法 / MASA法 / CEA遺伝子 / MAGE遺伝子 / k-ras遺伝子
Research Abstract

PURPOSE : This study evaluated the clinical significance and predictive values for patients' prognosis of micrometastasis in the lymph nodes and samples of patients' with gastrointestinal or breast carcinomas.
RESULTS : (A) BLOOD ; 1) Predictive values : Detection rate and sensitivity of cancer cells in peritumoral draining vein were increased using MACS(magnetic cell sorting system) for colon cancer patients. Of 7 cases with K-ras mutation in the draining vein, 2 cases (29%) developed recurrent disease after curative operation at 8 or 15 months, respectively. On the other hands, of 17 cases without K-ras mutation, only one case (6%) developed recurrence. 2) Application for clinical use : CEAmRNA was detected in peripheral bloods of 10 cases with recurrent or advanced disease before chemotherapy, CEAmRNA was disappeared in 3 cases (30%) during the therapy, this was useful for monitoring the chemotherapy. The patients who underwent operation could store their CEAmRNA negative blood for a … More transfusion, ensuring no contamination of cancer cells.
(B) LYMPH NODES : 1) Predictive value : Of twenty-eight patients with histologically negative but CEAmRNA positive lymph nodes (28/64=44%), 3 cases (1 gastric, 1 colon, 1 esophageal cancer) developed recurrent disease. 2) Application for clinical use : Detection rate and sensitivity of cancer cells in lymph nodes were increased by RT-PCR. The patients without micrometastasis in the sentinel lymph node might save axillary nodes dissection of early breast cancer patients. We have established prompt RT-PCR technique which can be preformed within 60 minutes for practical molecular diagnosis during operation.
CONCLUSION : It has been shown that RT-PCR is a powerful tool to detect very small number of cancer cells in the blood or the lymph nodes. The time-shortened RT-PCR technique is potentially very useful to determine the patients at high-risk for metastasis or patients indicative for less invasive surgery. It would be possible to choose various strategies for each case based on presence of mirometastasis. Less

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (24 results)

All Other

All Publications (24 results)

  • [Publications] Mori M et al: "Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transciption-polymerase chain reaction in patients with gastrointestinal or breast carcinomas."J Clin Oncol. 16. 128-132 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Mori M et al: "Motility related protein 1 (MRP 1/CD9) expression in colon cancer."Clin Cancer Res. 4. 1507-1510 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Tanaka S el at: "A novel frizzled gene identified in human esophageal carcinoma mediates APC/b-catenin signals."Proc Natl Acad Sci (USA). 95. 10164-10169 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Mori M et al: "Lack of DMBT1 expression in oesophageal, gastric and colon cancers."Br. J Cancer. 79. 211-213 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Tanaka S el at: "Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma."J Clin Invest. 103. 341-345 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Mimori K et al: "Cancer-specific chromosome alterations in the consitutive fragile region FRA3B."Proc Natl Acad Sci (USA).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Mori M et al: "Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerize chain reaction in patients with gastrointestinal or breast carcinomas"J Clin Oncol. 16. 128-132 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Mori M et al: "Motility related protein 1 (MRP1/CD9) expression in colon cancer"Clin Cancer Res. 4. 1507-1510 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Tanaka S et al: "A novel frizzled gene identified in human esophageal carcinoma mediates ACP/β-catenin signals"Proc Natl Acad Sci (USA). 95. 10164-10169 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Mori M et al: "Lack of DMBT2 expression in esophageal, gastric and colon cancers"Br J Cancer. 79. 211-213 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Tanaka S et al: "Biologic significance of asgiopoietin-2 expression in human hepatocellular carcinoma"J Clin Invest. 103. 341-345 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Minori K et al: "Cancer-specific chromosome alterations in the constitutive fragile region FRA3B"Proc Natl Acad Sci (USA). 96. 7456-7461 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Mori M et al: "Clinical significance of molecular detection of carcinoma cells in lymph modes and peripheral blood by reverse transcription-polymerase chain reaction in patients with fastrointestinal or breast carcinomas."J Clin Oncol. 16. 128-132 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] Mori M et al: "Motility related protein 1(MRP1/CD9)expression in colon cancer."Clin Cancer Res. 4. 1507-1510 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] Tanaka S et al: "A novel fizzled gene identified in human esophageal carcinoma mediates APC/β-catenin signals."Proc Natl Acad Sci(USA). 95. 10164-10169 (1998)

    • Related Report
      1999 Annual Research Report
  • [Publications] Mori M et al: "Lack of DMBT1 expression in oesophageal,gastric and colon cancers."Br J Cancer. 79. 211-213 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Tanaka S et al: "Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma."J Clin Invest. 103. 341-345 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Minori K et al: "Cancer-specific chromosome alterations in the constitutive fragile region FRA3B."Proc Natl Acad Sci(USA). 96. 7456-7461 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Mori M: "Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestiral or breast carcinomas." J Clin Oncol. 16. 128-132 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Mori M: "Motility related protein 1(MRP1/CD9) expression in colon cancer." Clin Cancer Res. 4. 1507-1510 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Mori M: "Lack of DMBT1 expression in oesophageal, gastric and colon cancer." Br J Cancer. 79. 211-213 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Shibuta K: "Association between restriction fragment length polymorphism of the L-mye gene and susceptibility to gastric cancer." Br J Surg.85. 681-684 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Tanaka S: "A novel frizzled gene identified in human esophageal carcinoma mediates APC/β-catenin signals." Proc Natl Acad Sci(USA). 95. 10164-10169 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Tanaka S: "A novel variant of human Grb7 is associated with invasive esophageal carcinoma." J Clin Invest. 102. 821-827 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi